ZBIO
ZBIO
US98937L1052
Zenas BioPharma, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.78B EUR
1.61B EUR
1.22B EUR
1.98B EUR
Enterprise Value
1.36B EUR
1.71B EUR
986.2M EUR
1.87B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-5.85x
--
--
--
Price to Sales
1,776.72x
1,607.33x
--
--
Price to Book
6.99x
6.5x
3.63x
8.17x
EV/Revenue
1,364.97x
1,708.62x
--
--
EV/EBITDA
-4.98x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-11.9%
-18.1%
-20.13%
-8.61%
ende